Uquifa Overview
- Founded
-
1936
- Status
-
Acquired/Merged
- Employees
-
329
- Latest Deal Type
-
Debt
- Financing Rounds
-
5
- Investments
-
1
Uquifa General Information
Description
Manufacturer of pharmaceutical products intended to offer contract-based services. The company offers items of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical and animal health industries globally which are produced in its regulatory authorities approved sites, providing the chemical industry with speedy delivery of high-quality products.
Contact Information
Website
www.uquifa.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Delivery
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- C/Mallorca 262
- 3rd floor
- 08008 Barcelona
- Spain
+34 934 00 00 00
Uquifa Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Uquifa Patents
Uquifa Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2163547-A1 | Process for the preparation of an oxazolidinone antibacterial agent and intermediates thereof | Inactive | 16-Sep-2008 | 0000000000 | 0 |
| ES-2291135-B1 | Procedure for the preparation of tartrate of (r) -tolterodine. | Inactive | 04-Jul-2006 | 0000000000 | |
| ES-2291135-A1 | Method for the preparation of (r)-tolterodine tartrate | Active | 04-Jul-2006 | 0000000000 | 0 |
| AU-2006331373-A1 | A process for the preparation of the (s)-enantiomer of omeprazole | Active | 28-Dec-2005 | 0000000000 | |
| AU-2006331373-B2 | A process for the preparation of the (s)-enantiomer of omeprazole | Inactive | 28-Dec-2005 | C07D401/12 |
Uquifa Executive Team (6)
Uquifa Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000000 000 | Uquifa | Board Member | 000 0000 |
| 0000000 00000000 | Uquifa | Board Member | 000 0000 |
| 0000000 00000000 | Vivimed Labs | Board Member | 000 0000 |
| 0000000 000000000 | Uquifa | Managing Director, Corporate Development & Strategy & Board Member | 000 0000 |
| 00000 000000 00 | Self | Board Member | 000 0000 |
Uquifa Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Uquifa Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Uquifa Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000000 | 01-May-2018 | 0000000000 | 000.00 | Laboratory Services (Healthcare) | 0000000 0 |
Uquifa Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 000000 000000000 | Laboratory Services (Healthcare) | Budapest, Hungary | 0000 |